Category Archives: – Policy

The best hospitals in the country are losing money. Why?

August 12, 2019- by Steven E. Greer, MD In the course of working on a medical book for the patient population, I just discovered this 2017 Forbes article that explains

Posted in - Policy, Cleveland Clinic, CMS, Columbia, Congress, Cornell, Harvard, NYU, Ohio State, UCLA, Univ Miami, Z Medical centers | Comments Off on The best hospitals in the country are losing money. Why?

The ISCHEMIA trial PI, Judith Hochman, makes egregiously unfounded statements on national TV

November 17, 2019- by Steven E. Greer, MD The big news from the 2019 American Heart Association meeting is the large trial known by the acronym ISCHEMIA.

Posted in - Opinion, - Pharma, Cardiac surgery, Cardiology, Congress, FDA, Internal Medicine, NYU, VA | 1 Comment

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment

Cardiology mafia egregiously obfuscates mortality differences between stents and CABG in EXCEL trial

December 10, 2019- by Steven E. Greer, MD In my recent book, The Medical Advocate, I excoriated the cardiology community, particularly

Posted in - Medical Devices, - NEJM, - Opinion, Cardiac surgery, Cardiology, FDA | Leave a comment

Daily aspirin once again proves to be of no use and also deadly

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. 

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment

Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital.

Dean and CEO of Johns Hopkins Medicine Paul Rothman December 11, 2018- by Steven E. Greer, MD Ranking colleges and medical centers is a futile, highly subjective, and ludicrous endeavor. Nevertheless,

Posted in - Policy, Cardiac surgery, Cardiology, Columbia, Johns Hopkins, Pediatrics | 3 Comments

The MusiCorps benefit concert 2015

October 16, 2015- by Steven E. Greer, MD We interviewed the Founder of MusiCorps, Arthur Bloom, and one of the musicians in the band,

Posted in - Policy, NIH, Orthopedic surgery, Plastic surgery, Psychology Psychiatry, Trauma Surgery, VA Walter Reed | Leave a comment

Don Berwick, MD: Waste in the American Healthcare System

Dr. Berwick, former Director of CMS and former President and CEO of IHI, discusses the percentage

Posted in CMS, Congress, Harvard | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

Benjamin Sommers, MD PhD: Expansion of Medicaid and impact on mortality rates

September 7, 2012

Posted in CMS, Harvard | Leave a comment

The 23andMe TV ads are misleading

April 22, 2019- by Steven E. Greer, MD

Posted in FDA, Genetics | Comments Off on The 23andMe TV ads are misleading

60 Minutes creates another publicist-paid puff-piece for an unethical medical researcher

December 8, 2019- by Steven E. Greer, MD CBS’ 60 Minutes featured an extremely unethical PhD medical researcher at Harvard named George

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Genetics, NIH | Leave a comment

A proposal to screen for mass shooters

August 5, 2019- by Steven E. Greer, MD President Trump today announced plans to have the Department of Justice create guidelines

Posted in - Opinion, - Policy, CDC, Congress, Psychology Psychiatry, Trauma Surgery | Comments Off on A proposal to screen for mass shooters

Essay: Opioids coming through the Mexican border are a national security risk

Update January 8, 2019- President Trump quoted from this story tonight during his talk from the Ova

Posted in - Opinion, - Pharma, - Policy, CDC, Congress, FDA, NIH, Primary care medicine, Rehab | Leave a comment

The Medical Advocate

Now available on Amazon. The Medical Advocate is an important book on the American healthcare system.

Posted in - Opinion, - Pharma, - Policy, - Reviews, books, devices, CDC, CMS, Congress, FDA, NIH | Comments Off on The Medical Advocate

Trying Beyond Meat for the first time

November 12, 2019- by Steven E. Greer, MD

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Internal Medicine, Neurology, Oncology, Pediatrics, Sports medicine, Vascular Surgery | Comments Off on Trying Beyond Meat for the first time

The Breville blender is an essential tool for a meatless diet

November 12, 2019- by Steven E. Greer, MD

Posted in - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Internal Medicine, Neurology, Oncology, Pediatrics, Sports medicine | Comments Off on The Breville blender is an essential tool for a meatless diet

Triple Therapy for Cystic Fibrosis

October 18, 2018- interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, FDA, Genetics, Infectious disease, Internal Medicine, National Jewish Health, Pediatrics, Pulmonology | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the

Posted in - Policy, FDA | Leave a comment